26 / 49
g
Coordinating the implementation of the European Strategic Plan;
g
Steering the integration of research, care and education, and increase
funding levels;
g
Ensuring that the EU legislative framework facilitates the
implementation of the Strategic Plan;
g
Strengthening partnerships with all stakeholders.
SIOPE is the European Society of Paediatric Oncology and is dedicated to
care, research and training in paediatric haematology-oncology as well as
policy-making for decisions that impact on cancer (‘oncopolicy’).
Its mission is to ensure the best possible care and outcome for all
children and young people with cancer in Europe, by increasing the cure
rate and the quality of cure of children with cancer. More specifically,
SIOPE is in charge of:
Coordination and implementation
of the Plan
SIOPE is the European branch of the International Society of Paediatric Oncology (SIOP) and a
founding member of the European Cancer Organization (ECCO).
Currently there are 19 European Clinical Trial Groups (ECTGs) developing clinical and translational
research either by an individual disease type (15 groups) or across multiple diseases (4 groups),
who define and run their own research strategy according to the SIOPE Strategic Plan. In Europe
there are also 25 National Paediatric Haematology-Oncology Societies (NaPHOS). The Chairs of
ECTGs and NaPHOS form the SIOPE Clinical Research Council (CRC, formerly ECRC).
THE SIOPE STRATEGIC PLAN
26
From AIEOP. Credit Attilio Rossetti
photographer, Italy
“Children are desperate to enrol in new clinical trials, that
in some cases can be the only hope for survival.” (Glenis
WiIlmott, Member of the European Parliament, UK)